| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cilia and flagella associated protein 221 | 0.805 | 0.231 | 8.7E-17 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
cilia and flagella associated protein 221 | 0.805 | 0.231 | 8.7E-17 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
Ral GTPase activating protein catalytic subunit alpha 1 | 0.861 | 0.231 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
Ral GTPase activating protein catalytic subunit alpha 1 | 0.861 | 0.231 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
triokinase and FMN cyclase | 0.839 | 0.192 | 3.2E-12 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
triokinase and FMN cyclase | 0.839 | 0.192 | 3.2E-12 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
triokinase and FMN cyclase | 0.839 | 0.192 | 3.2E-12 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
triokinase and FMN cyclase | 0.839 | 0.192 | 3.2E-12 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
protein phosphatase 1 regulatory subunit 12A | 0.626 | 0.615 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
protein phosphatase 1 regulatory subunit 12A | 0.626 | 0.615 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
disease | 0.400 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
disease | 0.410 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
trafficking protein particle complex 4 | 0.805 | 0.308 | 4.1E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
NAD synthetase 1 | 0.780 | 0.231 | 1.3E-16 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
NAD synthetase 1 | 0.780 | 0.231 | 1.3E-16 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2020 | 2020 |